These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27803322)

  • 1. S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.
    Chande A; Cuccurullo EC; Rosa A; Ziglio S; Carpenter S; Pizzato M
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13197-13202. PubMed ID: 27803322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.
    Ahi YS; Zhang S; Thappeta Y; Denman A; Feizpour A; Gummuluru S; Reinhard B; Muriaux D; Fivash MJ; Rein A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5.
    Ahmad I; Li S; Li R; Chai Q; Zhang L; Wang B; Yu C; Zheng YH
    J Biol Chem; 2019 Apr; 294(17):7013-7024. PubMed ID: 30862674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.
    Wu Y; Olety B; Weiss ER; Popova E; Yamanaka H; Göttlinger H
    mBio; 2019 Jun; 10(3):. PubMed ID: 31186327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
    Usami Y; Wu Y; Göttlinger HG
    Nature; 2015 Oct; 526(7572):218-23. PubMed ID: 26416733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
    Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
    J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Conserved Acidic-Cluster Motif in SERINC5 Confers Partial Resistance to Antagonism by HIV-1 Nef.
    Stoneham CA; Ramirez PW; Singh R; Suarez M; Debray A; Lim C; Jia X; Xiong Y; Guatelli J
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERINC5 Potently Restricts Retrovirus Infection
    Timilsina U; Umthong S; Lynch B; Stablewski A; Stavrou S
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins.
    Li M; Waheed AA; Yu J; Zeng C; Chen HY; Zheng YM; Feizpour A; Reinhard BM; Gummuluru S; Lin S; Freed EO; Liu SL
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5705-5714. PubMed ID: 30842281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor.
    Fackler OT
    Viruses; 2015 Dec; 7(12):6730-8. PubMed ID: 26703715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.
    Gonzalez-Enriquez GV; Escoto-Delgadillo M; Vazquez-Valls E; Torres-Mendoza BM
    J Immunol Res; 2017; 2017():1548905. PubMed ID: 29359168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists.
    de Sousa-Pereira P; Abrantes J; Bauernfried S; Pierini V; Esteves PJ; Keppler OT; Pizzato M; Hornung V; Fackler OT; Baldauf HM
    J Gen Virol; 2019 Feb; 100(2):278-288. PubMed ID: 30566072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.
    Zhang X; Zhou T; Yang J; Lin Y; Shi J; Zhang X; Frabutt DA; Zeng X; Li S; Venta PJ; Zheng YH
    J Virol; 2017 May; 91(10):. PubMed ID: 28275190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.
    Li S; Ahmad I; Shi J; Wang B; Yu C; Zhang L; Zheng YH
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates.
    Murrell B; Vollbrecht T; Guatelli J; Wertheim JO
    J Virol; 2016 Sep; 90(18):8085-9. PubMed ID: 27356902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4.
    Olety B; Usami Y; Wu Y; Peters P; Göttlinger H
    mBio; 2023 Feb; 14(1):e0338222. PubMed ID: 36622146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity.
    Diehl WE; Guney MH; Vanzo T; Kyawe PP; White JM; Pizzato M; Luban J
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue.
    Kmiec D; Akbil B; Ananth S; Hotter D; Sparrer KMJ; Stürzel CM; Trautz B; Ayouba A; Peeters M; Yao Z; Stagljar I; Passos V; Zillinger T; Goffinet C; Sauter D; Fackler OT; Kirchhoff F
    PLoS Pathog; 2018 Aug; 14(8):e1007269. PubMed ID: 30125328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
    Rosa A; Chande A; Ziglio S; De Sanctis V; Bertorelli R; Goh SL; McCauley SM; Nowosielska A; Antonarakis SE; Luban J; Santoni FA; Pizzato M
    Nature; 2015 Oct; 526(7572):212-7. PubMed ID: 26416734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
    Trautz B; Wiedemann H; Lüchtenborg C; Pierini V; Kranich J; Glass B; Kräusslich HG; Brocker T; Pizzato M; Ruggieri A; Brügger B; Fackler OT
    J Biol Chem; 2017 Aug; 292(33):13702-13713. PubMed ID: 28659343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.